
<div id="jpedal" style="overflow: hidden; position: relative; width: 909px; height: 1212px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_1{left:72px;top:98px;word-spacing:-0.4px;}
#t2_1{left:72px;top:114px;letter-spacing:-0.3px;word-spacing:0.3px;}
#t3_1{left:72px;top:131px;letter-spacing:-0.3px;word-spacing:2.5px;}
#t4_1{left:72px;top:148px;word-spacing:4.3px;}
#t5_1{left:72px;top:175px;word-spacing:4.2px;}
#t6_1{left:72px;top:201px;word-spacing:4.3px;}
#t7_1{left:72px;top:219px;word-spacing:6.5px;}
#t8_1{left:72px;top:237px;word-spacing:-2.8px;}
#t9_1{left:72px;top:254px;word-spacing:9px;}
#ta_1{left:72px;top:272px;word-spacing:15.3px;}
#tb_1{left:72px;top:289px;word-spacing:17.6px;}
#tc_1{left:72px;top:307px;letter-spacing:-0.3px;word-spacing:-2.6px;}
#td_1{left:72px;top:325px;letter-spacing:-0.2px;word-spacing:4.6px;}
#te_1{left:72px;top:342px;letter-spacing:-0.3px;word-spacing:15.5px;}
#tf_1{left:72px;top:360px;letter-spacing:-0.2px;word-spacing:-2.3px;}
#tg_1{left:72px;top:378px;letter-spacing:-0.2px;word-spacing:8.2px;}
#th_1{left:72px;top:395px;letter-spacing:-0.2px;word-spacing:3.5px;}
#ti_1{left:72px;top:413px;letter-spacing:-0.3px;word-spacing:-2.4px;}
#tj_1{left:72px;top:431px;letter-spacing:-0.2px;word-spacing:-0.6px;}
#tk_1{left:72px;top:448px;letter-spacing:-0.2px;word-spacing:7.9px;}
#tl_1{left:72px;top:466px;letter-spacing:-0.3px;word-spacing:2.3px;}
#tm_1{left:72px;top:493px;word-spacing:4.3px;}
#tn_1{left:72px;top:510px;letter-spacing:-0.2px;word-spacing:-0.4px;}
#to_1{left:72px;top:528px;letter-spacing:-0.2px;word-spacing:16px;}
#tp_1{left:72px;top:546px;letter-spacing:-0.3px;word-spacing:5.6px;}
#tq_1{left:72px;top:563px;letter-spacing:-0.2px;word-spacing:2.2px;}
#tr_1{left:72px;top:581px;letter-spacing:-0.3px;word-spacing:1.3px;}
#ts_1{left:72px;top:599px;letter-spacing:-0.2px;word-spacing:11.8px;}
#tt_1{left:72px;top:616px;letter-spacing:-0.3px;word-spacing:4.2px;}
#tu_1{left:72px;top:634px;letter-spacing:-0.3px;word-spacing:9.6px;}
#tv_1{left:72px;top:651px;letter-spacing:-0.3px;word-spacing:2.4px;}
#tw_1{left:91px;top:669px;letter-spacing:-0.2px;word-spacing:-2.9px;}
#tx_1{left:72px;top:687px;letter-spacing:-0.3px;word-spacing:0.7px;}
#ty_1{left:72px;top:704px;letter-spacing:-0.2px;word-spacing:0.6px;}
#tz_1{left:305px;top:704px;letter-spacing:-0.4px;}
#t10_1{left:322px;top:704px;letter-spacing:-0.2px;word-spacing:0.5px;}
#t11_1{left:72px;top:722px;letter-spacing:-0.3px;word-spacing:-4.5px;}
#t12_1{left:72px;top:740px;letter-spacing:-0.3px;word-spacing:3.5px;}
#t13_1{left:72px;top:757px;letter-spacing:-0.2px;word-spacing:11.1px;}
#t14_1{left:72px;top:775px;letter-spacing:-0.3px;word-spacing:7.9px;}
#t15_1{left:72px;top:793px;letter-spacing:-0.3px;word-spacing:14.6px;}
#t16_1{left:72px;top:810px;letter-spacing:-0.2px;word-spacing:14px;}
#t17_1{left:72px;top:828px;letter-spacing:-0.3px;}
#t18_1{left:126px;top:828px;letter-spacing:-0.4px;}
#t19_1{left:144px;top:828px;}
#t1a_1{left:91px;top:846px;word-spacing:12.6px;}
#t1b_1{left:72px;top:863px;word-spacing:6.2px;}
#t1c_1{left:72px;top:881px;word-spacing:8.8px;}
#t1d_1{left:72px;top:899px;word-spacing:3.4px;}
#t1e_1{left:229px;top:899px;}
#t1f_1{left:247px;top:899px;word-spacing:3.6px;}
#t1g_1{left:72px;top:916px;word-spacing:-1.7px;}
#t1h_1{left:313px;top:916px;}
#t1i_1{left:330px;top:916px;word-spacing:-1.6px;}
#t1j_1{left:72px;top:934px;word-spacing:10.4px;}
#t1k_1{left:72px;top:952px;word-spacing:3.5px;}
#t1l_1{left:72px;top:969px;word-spacing:14px;}
#t1m_1{left:72px;top:987px;word-spacing:11.8px;}
#t1n_1{left:72px;top:1005px;word-spacing:-2.4px;}
#t1o_1{left:158px;top:1005px;}
#t1p_1{left:175px;top:1005px;word-spacing:-2.3px;}
#t1q_1{left:72px;top:1022px;word-spacing:4.5px;}
#t1r_1{left:72px;top:1040px;word-spacing:-1.3px;}
#t1s_1{left:72px;top:1058px;word-spacing:7.8px;}
#t1t_1{left:72px;top:1075px;word-spacing:12.4px;}
#t1u_1{left:72px;top:1093px;word-spacing:8.6px;}
#t1v_1{left:72px;top:1111px;word-spacing:2.3px;}
#t1w_1{left:465px;top:98px;word-spacing:3.5px;}
#t1x_1{left:465px;top:116px;word-spacing:-0.6px;}
#t1y_1{left:465px;top:133px;word-spacing:10.4px;}
#t1z_1{left:465px;top:151px;word-spacing:1.1px;}
#t20_1{left:483px;top:169px;word-spacing:17px;}
#t21_1{left:465px;top:186px;word-spacing:10.2px;}
#t22_1{left:465px;top:204px;word-spacing:-0.5px;}
#t23_1{left:465px;top:222px;word-spacing:25.2px;}
#t24_1{left:465px;top:239px;word-spacing:29.1px;}
#t25_1{left:465px;top:257px;word-spacing:8.9px;}
#t26_1{left:465px;top:274px;word-spacing:30px;}
#t27_1{left:465px;top:292px;word-spacing:21.7px;}
#t28_1{left:465px;top:310px;word-spacing:7.1px;}
#t29_1{left:465px;top:327px;word-spacing:15px;}
#t2a_1{left:465px;top:345px;word-spacing:-1.7px;}
#t2b_1{left:465px;top:363px;word-spacing:15px;}
#t2c_1{left:465px;top:380px;word-spacing:4.4px;}
#t2d_1{left:465px;top:398px;word-spacing:-2.8px;}
#t2e_1{left:465px;top:416px;word-spacing:8.5px;}
#t2f_1{left:465px;top:433px;word-spacing:-2.3px;}
#t2g_1{left:465px;top:451px;word-spacing:24.7px;}
#t2h_1{left:465px;top:469px;word-spacing:4.3px;}
#t2i_1{left:483px;top:486px;word-spacing:2.7px;}
#t2j_1{left:465px;top:504px;word-spacing:15.8px;}
#t2k_1{left:465px;top:522px;word-spacing:11.5px;}
#t2l_1{left:465px;top:539px;word-spacing:5.4px;}
#t2m_1{left:465px;top:557px;letter-spacing:-0.3px;word-spacing:-2.9px;}
#t2n_1{left:465px;top:575px;letter-spacing:-0.2px;word-spacing:13.4px;}
#t2o_1{left:465px;top:592px;letter-spacing:-0.2px;word-spacing:3px;}
#t2p_1{left:745px;top:592px;letter-spacing:-0.4px;}
#t2q_1{left:766px;top:592px;letter-spacing:-0.2px;word-spacing:2.6px;}
#t2r_1{left:465px;top:610px;letter-spacing:-0.2px;word-spacing:-4.6px;}
#t2s_1{left:465px;top:628px;letter-spacing:-0.2px;word-spacing:7px;}
#t2t_1{left:465px;top:645px;letter-spacing:-0.2px;word-spacing:1.6px;}
#t2u_1{left:465px;top:663px;letter-spacing:-0.2px;word-spacing:7.7px;}
#t2v_1{left:694px;top:663px;}
#t2w_1{left:708px;top:663px;letter-spacing:-0.2px;word-spacing:7.5px;}
#t2x_1{left:465px;top:681px;letter-spacing:-0.3px;word-spacing:2.8px;}
#t2y_1{left:465px;top:698px;letter-spacing:-0.2px;word-spacing:2.2px;}
#t2z_1{left:483px;top:716px;word-spacing:9px;}
#t30_1{left:465px;top:734px;word-spacing:10.5px;}
#t31_1{left:465px;top:751px;word-spacing:6.4px;}
#t32_1{left:465px;top:769px;word-spacing:-0.9px;}
#t33_1{left:465px;top:787px;word-spacing:1.3px;}
#t34_1{left:465px;top:804px;word-spacing:-0.6px;}
#t35_1{left:465px;top:822px;word-spacing:16.8px;}
#t36_1{left:465px;top:840px;word-spacing:-1.8px;}
#t37_1{left:465px;top:857px;word-spacing:-2.1px;}
#t38_1{left:465px;top:875px;word-spacing:1.4px;}
#t39_1{left:465px;top:893px;word-spacing:4.3px;}
#t3a_1{left:465px;top:931px;word-spacing:10.4px;}
#t3b_1{left:577px;top:931px;word-spacing:10.6px;}
#t3c_1{left:465px;top:947px;word-spacing:1.7px;}
#t3d_1{left:465px;top:963px;word-spacing:3.8px;}
#t3e_1{left:465px;top:1003px;}
#t3f_1{left:470px;top:1032px;}
#t3g_1{left:491px;top:1032px;word-spacing:8.1px;}
#t3h_1{left:491px;top:1048px;word-spacing:1.3px;}
#t3i_1{left:491px;top:1065px;}
#t3j_1{left:470px;top:1081px;}
#t3k_1{left:491px;top:1081px;word-spacing:3.3px;}
#t3l_1{left:491px;top:1097px;word-spacing:1.8px;}
#t3m_1{left:491px;top:1113px;}
#t3n_1{left:324px;top:50px;letter-spacing:6.5px;word-spacing:4.5px;}
#t3o_1{left:72px;top:47px;}

.s4_1{
	FONT-SIZE: 51.8px;
	FONT-FAMILY: NOOHDI-AdvP4C4E511;
	color: rgb(0,0,0);
}

.s5_1{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: NOOGDL-AdvP4DF6121;
	color: rgb(0,0,0);
}

.s9_1{
	FONT-SIZE: 39px;
	FONT-FAMILY: NOOGBL-AdvP4DF60E1;
	color: rgb(0,0,0);
}

.s6_1{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: NOOGBL-AdvP4DF60E1;
	color: rgb(0,0,0);
}

.s10_1{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: NOOGAK-AdvP4DF6141;
	color: rgb(0,0,0);
}

.s3_1{
	FONT-SIZE: 51.8px;
	FONT-FAMILY: NOOGBL-AdvP4DF60E1;
	color: rgb(0,104,156);
}

.s7_1{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: NOOGBL-AdvP4DF60E1;
	color: rgb(35,31,32);
}

.s1_1{
	FONT-SIZE: 51.8px;
	FONT-FAMILY: NOOGAK-AdvP4DF6141;
	color: rgb(0,0,0);
}

.s2_1{
	FONT-SIZE: 51.8px;
	FONT-FAMILY: NOOGBL-AdvP4DF60E1;
	color: rgb(0,0,0);
}

.s8_1{
	FONT-SIZE: 42.6px;
	FONT-FAMILY: NOOGBL-AdvP4DF60E1;
	color: rgb(0,104,156);
}

.v1_1{
	-webkit-transform: scale(0.259, 0.25);
	-ms-transform: scale(0.259, 0.25);
	-moz-transform: scale(0.259, 0.25);
	-o-transform: scale(0.259, 0.25);
}

#form1_1{	border-style:none;	z-index:2;	position: absolute;	left:304px;	top:706px;	width:19px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form1_2{	border-style:none;	z-index:2;	position: absolute;	left:744px;	top:594px;	width:19px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form1_3{	border-style:none;	z-index:2;	position: absolute;	left:125px;	top:830px;	width:19px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form1_4{	border-style:none;	z-index:2;	position: absolute;	left:312px;	top:918px;	width:20px;	height:14px;	text-align:left;	background: transparent;	font:normal 10px Arial, Helvetica, sans-serif;}
#form1_5{	border-style:none;	z-index:2;	position: absolute;	left:158px;	top:1005px;	width:19px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form1_6{	border-style:none;	z-index:2;	position: absolute;	left:228px;	top:900px;	width:20px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form1_7{	border-style:none;	z-index:2;	position: absolute;	left:200px;	top:776px;	width:29px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form1_8{	border-style:none;	z-index:2;	position: absolute;	left:491px;	top:1114px;	width:37px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_9{	border-style:none;	z-index:2;	position: absolute;	left:491px;	top:1065px;	width:40px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_10{	border-style:none;	z-index:2;	position: absolute;	left:491px;	top:1097px;	width:341px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_11{	border-style:none;	z-index:2;	position: absolute;	left:491px;	top:1082px;	width:341px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_12{	border-style:none;	z-index:2;	position: absolute;	left:491px;	top:1050px;	width:341px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}
#form1_13{	border-style:none;	z-index:2;	position: absolute;	left:491px;	top:1033px;	width:341px;	height:12px;	text-align:left;	background: transparent;	font:normal 9px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts1" type="text/css" >

@font-face {
	font-family: NOOGAK-AdvP4DF6141;
	src: url("1/fonts/NOOGAK-AdvP4DF614.woff") format("woff");
}

@font-face {
	font-family: NOOGBL-AdvP4DF60E1;
	src: url("1/fonts/NOOGBL-AdvP4DF60E.woff") format("woff");
}

@font-face {
	font-family: NOOHDI-AdvP4C4E511;
	src: url("1/fonts/NOOHDI-AdvP4C4E51.woff") format("woff");
}

@font-face {
	font-family: NOOGDL-AdvP4DF6121;
	src: url("1/fonts/NOOGDL-AdvP4DF612.woff") format("woff");
}

</style>
<div id="t1_1" class="t v1_1 s1_1">Re: Tadalafil for Prevention of Erectile Dysfunction After</div>
<div id="t2_1" class="t v1_1 s1_1">Radiotherapy for Prostate Cancer: The Radiation Therapy</div>
<div id="t3_1" class="t v1_1 s1_1">Oncology Group [0831] Randomized Clinical Trial</div>
<div id="t4_1" class="t v1_1 s2_1">Pisansky TM, Pugh SL, Greenberg RE, et al.</div>
<div id="t5_1" class="t s2_1">JAMA 2014;311:1300–7</div>
<div id="t6_1" class="t s1_1">Experts’ summary:</div>
<div id="t7_1" class="t s2_1">Pisansky et al. are to be commended for their double-blind,</div>
<div id="t8_1" class="t s2_1">76-site international study examining the use of daily tadalafil</div>
<div id="t9_1" class="t s2_1">to evaluate the recovery of erectile function after radiation</div>
<div id="ta_1" class="t s2_1">therapy for prostate cancer (PCa). Men undergoing either</div>
<div id="tb_1" class="t s2_1">external-beam radiation therapy (EBRT) or brachytherapy</div>
<div id="tc_1" class="t s2_1">were enrolled and randomized to either the phosphodiesterase</div>
<div id="td_1" class="t s2_1">type 5 inhibitor (PDE5-I) tadalafil (5 mg) or placebo. In total,</div>
<div id="te_1" class="t s2_1">112 men received tadalafil and 109 received placebos for</div>
<div id="tf_1" class="t s2_1">24 consecutive weeks commencing 7 d after initiation of radia-</div>
<div id="tg_1" class="t s2_1">tion treatment. The primary end point was unaided erectile</div>
<div id="th_1" class="t s2_1">function 28–30 wk after radiation therapy (4–6 wk following</div>
<div id="ti_1" class="t s2_1">cessation of the randomized medication). Erectile function was</div>
<div id="tj_1" class="t s2_1">retained to similar degrees in the study arms at both 6 mo and</div>
<div id="tk_1" class="t s2_1">12 mo, with no significant differences observed in any sub-</div>
<div id="tl_1" class="t s2_1">domain of the International Index of Erectile Function.</div>
<div id="tm_1" class="t s1_1">Experts’ comments:</div>
<div id="tn_1" class="t s2_1">As with all studies examining erectile function after treatment</div>
<div id="to_1" class="t s2_1">for PCa, difficulties are evident in patient selection, given</div>
<div id="tp_1" class="t s2_1">patients’ preoperative sexual and urinary function as well as</div>
<div id="tq_1" class="t s2_1">PCa stage and grade, surgery performed, patient adherence to</div>
<div id="tr_1" class="t s2_1">treatment, and/or amount of radiation administered. Pisansky</div>
<div id="ts_1" class="t s2_1">et al. have valiantly tried to control for a large number of</div>
<div id="tt_1" class="t s2_1">variables; however, they were forced to acknowledge several</div>
<div id="tu_1" class="t s2_1">limitations including substantial patient attrition. Neverthe-</div>
<div id="tv_1" class="t s2_1">less, the results are interesting and worthy of discussion.</div>
<div id="tw_1" class="t v1_1 s2_1">Following treatment, be it surgery or radiation, there is an</div>
<div id="tx_1" class="t v1_1 s2_1">immediate insult to erectile function that evokes a continu-</div>
<div id="ty_1" class="t v1_1 s2_1">ous decline beyond 1 yr after therapy</div>
<div id="tz_1" class="t v1_1 s3_1">[1]</div>
<div id="t10_1" class="t v1_1 s2_1">. Such ongoing and</div>
<div id="t11_1" class="t v1_1 s2_1">progressive damage is the result of a combination of vascular,</div>
<div id="t12_1" class="t v1_1 s2_1">neural, and endothelial damage that contributes to periph-</div>
<div id="t13_1" class="t v1_1 s2_1">eral nerve damage, corporal hypoxia, and fibrosis due to</div>
<div id="t14_1" class="t v1_1 s2_1">persistent flaccidity [1,2]. As demonstrated in human and</div>
<div id="t15_1" class="t v1_1 s2_1">rodent models, surgical changes after prostatectomy are</div>
<div id="t16_1" class="t v1_1 s2_1">decreased with the use of peri- and postoperative daily</div>
<div id="t17_1" class="t v1_1 s2_1">tadalafil</div>
<div id="t18_1" class="t v1_1 s3_1">[2]</div>
<div id="t19_1" class="t v1_1 s2_1">.</div>
<div id="t1a_1" class="t v1_1 s2_1">Padma-Nathan et al. performed the first randomized,</div>
<div id="t1b_1" class="t v1_1 s2_1">placebo-controlled clinical trial that found daily sildenafil</div>
<div id="t1c_1" class="t v1_1 s2_1">contributed to significant improvements in erectile func-</div>
<div id="t1d_1" class="t v1_1 s2_1">tion after prostatectomy</div>
<div id="t1e_1" class="t v1_1 s3_1">[3]</div>
<div id="t1f_1" class="t v1_1 s2_1">. This was followed by numer-</div>
<div id="t1g_1" class="t v1_1 s2_1">ous studies (reviewed by Al Shaiji et al.</div>
<div id="t1h_1" class="t v1_1 s3_1">[2]</div>
<div id="t1i_1" class="t v1_1 s2_1">) that highlighted</div>
<div id="t1j_1" class="t v1_1 s2_1">the benefits of PDE5-Is, alprostadil, the vacuum erection</div>
<div id="t1k_1" class="t v1_1 s2_1">device (VED), MUSE, intracorporal injection, and combina-</div>
<div id="t1l_1" class="t v1_1 s2_1">tions thereof in postprostatectomy penile rehabilitation.</div>
<div id="t1m_1" class="t v1_1 s2_1">However, until the recent papers by Pisansky et al. and</div>
<div id="t1n_1" class="t v1_1 s2_1">Zelefsky et al.</div>
<div id="t1o_1" class="t v1_1 s3_1">[4]</div>
<div id="t1p_1" class="t v1_1 s2_1">, no significant studies had been conducted</div>
<div id="t1q_1" class="t v1_1 s2_1">examining rehabilitation in patients receiving brachyther-</div>
<div id="t1r_1" class="t v1_1 s2_1">apy or EBRT. Although translating the evidence gained from</div>
<div id="t1s_1" class="t v1_1 s2_1">the postprostatectomy literature to EBRT is possible, it is</div>
<div id="t1t_1" class="t v1_1 s2_1">important to consider that the potential mechanisms of</div>
<div id="t1u_1" class="t v1_1 s2_1">cavernous nerve injury during surgery are different from</div>
<div id="t1v_1" class="t v1_1 s2_1">those obtained during radiotherapy. Use of PDE5-Is results</div>
<div id="t1w_1" class="t v1_1 s2_1">in cavernous nerve regeneration following crush injury, as</div>
<div id="t1x_1" class="t v1_1 s2_1">happens during surgery. However, since the exact nature of</div>
<div id="t1y_1" class="t v1_1 s2_1">injury following EBRT remains unclear, PDE5-Is may not</div>
<div id="t1z_1" class="t v1_1 s2_1">have the similar beneficial effects on the cavernous nerves.</div>
<div id="t20_1" class="t v1_1 s2_1">Traditionally, elderly men were offered radiotherapy</div>
<div id="t21_1" class="t v1_1 s2_1">versus younger men who were offered surgery. As such,</div>
<div id="t22_1" class="t v1_1 s2_1">studies into the outcomes of penile rehabilitation following</div>
<div id="t23_1" class="t v1_1 s2_1">EBRT were not previously conducted because it was</div>
<div id="t24_1" class="t v1_1 s2_1">hypothesized that results would be affected by the</div>
<div id="t25_1" class="t v1_1 s2_1">differences in patient age and preoperative function. The</div>
<div id="t26_1" class="t v1_1 s2_1">advent of intensity-modulated radiation therapy and</div>
<div id="t27_1" class="t v1_1 s2_1">computer-based targeting of the prostate has allowed</div>
<div id="t28_1" class="t v1_1 s2_1">younger men to seriously consider EBRT as their primary</div>
<div id="t29_1" class="t v1_1 s2_1">form of PCa treatment. Presumably, this would lead to</div>
<div id="t2a_1" class="t v1_1 s2_1">younger men with improved pretreatment erectile function</div>
<div id="t2b_1" class="t v1_1 s2_1">being offered EBRT. In this vein, the cohort studied by</div>
<div id="t2c_1" class="t v1_1 s2_1">Pisansky et al. had a median age of 63 yr, with 68% of the</div>
<div id="t2d_1" class="t v1_1 s2_1">study population under the age of 65 yr. Given that Pisansky</div>
<div id="t2e_1" class="t v1_1 s2_1">et al. found that age was the only factor associated with</div>
<div id="t2f_1" class="t v1_1 s2_1">overall worsening of sexual function over time, this variable</div>
<div id="t2g_1" class="t v1_1 s2_1">appears to play a significant role in sexual function</div>
<div id="t2h_1" class="t v1_1 s2_1">outcomes, given these conditions.</div>
<div id="t2i_1" class="t v1_1 s2_1">PDE5-Is have always been considered the foundation of</div>
<div id="t2j_1" class="t v1_1 s2_1">many penile rehabilitation protocols. When considering</div>
<div id="t2k_1" class="t v1_1 s2_1">dosages, Pisansky et al. administered PDE5-Is for 24 wk</div>
<div id="t2l_1" class="t v1_1 s2_1">(6 mo), a time course that effectively captures declines at</div>
<div id="t2m_1" class="t v1_1 s2_1">both peak (approximately 2 mo) and plateau (approximately</div>
<div id="t2n_1" class="t v1_1 s2_1">6–24 mo) in the Sexual Score of the Expanded Prostate</div>
<div id="t2o_1" class="t v1_1 s2_1">Cancer Index, as documented by Sanda et al.</div>
<div id="t2p_1" class="t v1_1 s3_1">[5]</div>
<div id="t2q_1" class="t v1_1 s2_1">after EBRT</div>
<div id="t2r_1" class="t v1_1 s2_1">and brachytherapy. Although it is unclear whether treatment</div>
<div id="t2s_1" class="t v1_1 s2_1">for a longer duration could have made a difference in the</div>
<div id="t2t_1" class="t v1_1 s2_1">recovery of erections in the study by Pisansky et al., men in</div>
<div id="t2u_1" class="t v1_1 s2_1">future studies should be treated for</div>
<div id="t2v_1" class="t v1_1 s4_1">&gt;</div>
<div id="t2w_1" class="t v1_1 s2_1">12 mo to minimize</div>
<div id="t2x_1" class="t v1_1 s2_1">corporal fibrosis and optimize penile oxygenation through-</div>
<div id="t2y_1" class="t v1_1 s2_1">out the period of penile hypoxia following EBRT.</div>
<div id="t2z_1" class="t v1_1 s2_1">Another factor to consider is that Pisansky et al. used</div>
<div id="t30_1" class="t v1_1 s2_1">only one agent in their rehabilitation protocol. Although</div>
<div id="t31_1" class="t v1_1 s2_1">compliance with PDE5-I use may have contributed to the</div>
<div id="t32_1" class="t v1_1 s2_1">high rates of patient attrition in the study by Pisansky et al.,</div>
<div id="t33_1" class="t v1_1 s2_1">a multimodality approach (ie, combined PDE5-I, ICI, MUSE,</div>
<div id="t34_1" class="t v1_1 s2_1">and VED) may prove to be the most successful, even in men</div>
<div id="t35_1" class="t v1_1 s2_1">with radiotherapy. This would be due not only to the</div>
<div id="t36_1" class="t v1_1 s2_1">variable effects on penile physiology, decreased fibrosis and</div>
<div id="t37_1" class="t v1_1 s2_1">oxygenation, but also to the simple fact that such an intense</div>
<div id="t38_1" class="t v1_1 s2_1">regiment would serve to self-select those men who are the</div>
<div id="t39_1" class="t v1_1 s2_1">most dedicated in continuing the process.</div>
<div id="t3a_1" class="t s5_1">Conﬂicts of interest:</div>
<div id="t3b_1" class="t s6_1">Larry I. Lipshultz is a clinical trials participant,</div>
<div id="t3c_1" class="t s6_1">consultant, and speaker for Auxilium and Endo. The other authors have</div>
<div id="t3d_1" class="t s6_1">nothing to disclose.</div>
<div id="t3e_1" class="t v1_1 s1_1">References</div>
<div id="t3f_1" class="t s7_1">[1]</div>
<div id="t3g_1" class="t s8_1">Pinkawa M, Gagel B, Piroth MD, et al. Erectile dysfunction after</div>
<div id="t3h_1" class="t s8_1">external beam radiotherapy for prostate cancer. Eur Urol 2009;55:</div>
<div id="t3i_1" class="t s8_1">227–36.</div>
<div id="t3j_1" class="t s7_1">[2]</div>
<div id="t3k_1" class="t s8_1">Al Shaiji TA, Chb M, Brock G. Should penile rehabilitation become</div>
<div id="t3l_1" class="t s8_1">the norm following radical prostatectomy? Can Urol Assoc J 2009;</div>
<div id="t3m_1" class="t s8_1">3:50–3.</div>
<div id="t3n_1" class="t s9_1">EUROPEAN UROLOGY 66 (2014) 593–598</div>
<div id="t3o_1" class="t s10_1">594</div>

<form>
<input type="button"  tabindex="1"  id="form1_1" name="39 0 R"  pdfFieldName="39 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="7"  id="form1_2" name="45 0 R"  pdfFieldName="45 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="3"  id="form1_3" name="41 0 R"  pdfFieldName="41 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="5"  id="form1_4" name="43 0 R"  pdfFieldName="43 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="6"  id="form1_5" name="44 0 R"  pdfFieldName="44 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="4"  id="form1_6" name="42 0 R"  pdfFieldName="42 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="2"  id="form1_7" name="40 0 R"  pdfFieldName="40 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="13"  id="form1_8" name="51 0 R"  pdfFieldName="51 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0010','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0010" />
<input type="button"  tabindex="10"  id="form1_9" name="48 0 R"  pdfFieldName="48 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0005','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0005" />
<input type="button"  tabindex="12"  id="form1_10" name="50 0 R"  pdfFieldName="50 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0010','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0010" />
<input type="button"  tabindex="11"  id="form1_11" name="49 0 R"  pdfFieldName="49 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0010','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0010" />
<input type="button"  tabindex="9"  id="form1_12" name="47 0 R"  pdfFieldName="47 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0005','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0005" />
<input type="button"  tabindex="8"  id="form1_13" name="46 0 R"  pdfFieldName="46 0 R" onclick="window.open('http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0005','_blank');" style="cursor:pointer;" title="http://refhub.elsevier.com/S0302-2838(14)00603-4/sbref0005" />

</form>
<div id="pg1Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg1"><object width="909" height="1212" data="1/1.svg" type="image/svg+xml" id="pdf1" style="width:909px; height:1212px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 133;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_1");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
